Jaguar Health (JAGX) Tax Provisions (2017 - 2019)

Jaguar Health's (JAGX) quarterly Tax Provisions came in at $10000.0 in Q3 2019, up 101.01% on a QoQ basis from -$990549.0 in Q4 2017.

Jaguar Health (JAGX) Tax Provisions (2017 - 2019) Analysis & Trends

Jaguar Health (JAGX) has 2 years of Tax Provisions data on file, last reported at $10000.0 in Q3 2019.

On a quarterly basis, Tax Provisions changed N/A year-over-year to $10000.0 in Q3 2019; TTM through Jun 2023 was $10000.0, a N/A change from a year earlier, with the FY2019 full-year figure at $10000.0, changed N/A from the prior year.
Tax Provisions for Q3 2019 stood at $10000.0, up from -$990549.0 in the prior quarter.
Over the last five years, Tax Provisions for JAGX reached as high as $10000.0 in Q3 2019 and fell as low as -$12.2 million in Q3 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Nanobiotix	1,785.82 Bn	1,785.76 Bn	-	-
2	Akari Therapeutics	979.03 Bn	979.03 Bn	-	-859,000.00
3	BeOne Medicines	473.37 Bn	468.58 Bn	1.35 Bn	31.86 Mn
4	Vertex Pharmaceuticals	123.58 Bn	116.33 Bn	2.59 Bn	221.50 Mn
5	Regeneron Pharmaceuticals	71.54 Bn	62.78 Bn	3.31 Bn	104.00 Mn
6	Belite Bio	62.17 Bn	62.17 Bn	-	-
7	Argenx Se	54.63 Bn	49.44 Bn	1.41 Bn	59.00 Mn
8	Alnylam Pharmaceuticals	38.11 Bn	35.10 Bn	959.66 Mn	15.66 Mn
9	Revolution Medicines	36.17 Bn	36.17 Bn	-	-
10	Jaguar Health	523,524.81	-9.54 Mn	19.11 Mn	-

Download Data